NYSE:SAP charts & data provided by TradingView

Latest Insights on SAP

Lovesace and I'll never leave the house meme main Lovesac’s Lovefest; Roku’s Rabble Rousers; A Stitch Fix In Time… December 8, 2021 by Joseph Hargett Great Stuff Lovesac, Baby! If you see amazing earnings at the side of the road, it means a 9% rally for Loooovesac! Lovesac, yeah yeah! We’re heading down the Wall Street highway, looking for a Lovesac getaway. Heading for a Lovesac (Nasdaq: ) getaway. I got me some earnings — they’re as big as a whale — […]
market crash defense MARKET CRASH? Here’s Your Best Line of Defense! December 6, 2021 by Angela Jirau Big Picture. Big Profits., Investing Well, we told you volatility was coming … and we got it in spades last week! The immediate cause is Omicron and the Federal Reserve’s hawkish turn. But the real problem is excessive valuations and leverage. Even when the market eventually recovers, those two threats can cause a SHARP correction, just as they did during […]
omicron covid-19 variant Your Omicron Investing Game Plan December 3, 2021 by Lina Lee Investment Opportunities, Real Talk, Stocks, U.S. Economy (3-minute read) Omicron is sparking another round of ups and downs for the markets. But Charles kept you covered this week with an investing game plan for this changing new normal…
December's Market Outlook: Buy the Omicron Dip! December’s Market Outlook: Buy the Omicron Dip! December 1, 2021 by Chris Cimorelli Monthly Market Outlook, Trading Strategies, True Options Masters In the last Monthly Market Outlook of the year, your True Options Masters share actionable trade ideas to buy the omicron dip!
omicron Adagio Therapeutics A Stock-Picking Mutation to Beat the Omicron Threat November 30, 2021 by Ted Bauman Big Picture. Big Profits., Global Economy, News This is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“Thirteen of my positions are up well over 50% in less than a year since joining your service. Two are in the triple digits with several close behind. My personal money manager, who works for one of the largest banks in the country, is envious of my gains. I never dreamed this was possible. My trips to China to teach English to young Chinese students is now much more affordable. Thank you for your dedication and help.”

- Chris K.

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

Share This